ADIPOQ and familial hypercholesterolemia: Substantial evidence from clinical and experimental studies has demonstrated that alterations in cholesterol and lipoprotein metabolism [5] such as reduced bile acid excretion [6], decreased apolipoprotein E concentration, [7] and impaired adiponectin function [8] play an important role in hypercholesterolemia related to the incidence of CVDs.